Role of GDF-15 in diabetic nephropathy: mechanisms, diagnosis, and therapeutic potential

被引:1
|
作者
Zhang, Xin [1 ]
Zhou, Chen-gang [1 ]
Ma, Li-jia [1 ,2 ]
机构
[1] Shanghai Jiao Tong Univ, Renji Hosp, Sch Med, Clin Lab, Shanghai 201100, Peoples R China
[2] Shanghai Jiao Tong Univ, Renji Hosp, Sch Med, Pathol Dept, Shanghai 201100, Peoples R China
关键词
Circulating growth differentiation factor 15; Diabetic nephropathy; Progression; DIFFERENTIATION FACTOR 15; PROGNOSIS; FACTOR-15; BIOMARKER; TYPE-1; IDENTIFICATION; MORTALITY; CYTOKINE; CACHEXIA; PATHWAY;
D O I
10.1007/s11255-024-04179-2
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
PurposeGrowth differentiation factor 15 (GDF-15) is a cytokine involved in regulating homeostasis, and its expression is up-regulated in response to injury, stress, and inflammation. This study explored the role of GDF-15 in diabetic nephropathy (DN), a severe complication of diabetes mellitus, and its potential as a biomarker for disease progression.MethodsAs a member of the transforming growth factor-beta superfamily, GDF-15 exhibits its renal protective functions primarily through its anti-inflammatory effects and the up-regulation of other renal protective factors. This study evaluated the association between circulating GDF-15 levels and DN progression, examining the underlying mechanisms.ResultsCirculating GDF-15 levels are closely linked to the development and progression of DN. While existing research has yielded some consistent conclusions, a comprehensive understanding of the role of GDF-15 in DN pathogenesis is needed to identify new therapeutic targets and strategies.ConclusionGDF-15 has the potential to be a prognostic and diagnostic biomarker for DN. It is crucial to establish appropriate reference ranges and explore their clinical utility in routine practice for validating the role of GDF-15 in DN management. Further interventional studies are required to confirm its clinical value in diagnosing and predicting the progression of DN.
引用
收藏
页码:169 / 175
页数:7
相关论文
共 50 条
  • [1] GDF-15: A Multifunctional Modulator and Potential Therapeutic Target in Cancer
    Fang, Lei
    Li, Fengzhou
    Gu, Chundong
    CURRENT PHARMACEUTICAL DESIGN, 2019, 25 (06) : 654 - 662
  • [2] Interplay between Senescence and Macrophages in Diabetic Cardiomyopathy: A Review of the Potential Role of GDF-15 and Klotho
    Almohaimeed, Ghada M.
    Alonazi, Asma S.
    Bin Dayel, Anfal F.
    Alshammari, Tahani K.
    Alghibiwi, Hanan K.
    Alamin, Maha A.
    Almotairi, Ahmad R.
    Alrasheed, Nouf M.
    BIOMEDICINES, 2024, 12 (04)
  • [3] GDF-15: A Potential Biomarker and Therapeutic Target in Systemic Lupus Erythematosus
    Xu, Wang-Dong
    Huang, Qi
    Yang, Chan
    Li, Rong
    Huang, An-Fang
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [4] Effects of GDF-15 Level in Patients with Membranous Nephropathy
    Adikozalova, Aida
    Akgul, Sebahat Usta
    Demir, Erol
    Ciftci, Hayriye Senturk
    Oguz, Fatma Savran
    Yazici, Halil
    Cinar, Cigdem Kekik
    EXPERIMED, 2024, 14 (01): : 40 - 45
  • [5] GDF-15 and colorectal cancer. Comparison between GDF-15, CA19.9 and CEA AT diagnosis
    Castillo Perez, C.
    Tahiri Bachiri, N.
    Rodriguez Alonso, L.
    Cebrian Ballesteros, M.
    Torrubia Dodero, B.
    CLINICA CHIMICA ACTA, 2024, 558 : 27 - 28
  • [6] GDF-15: Diagnostic, prognostic, and therapeutic significance in glioblastoma multiforme
    Segherlou, Zahra Hasanpour
    Nouri-Vaskeh, Masoud
    Guilandehi, Sama Noroozi
    Baghbanzadeh, Amir
    Zand, Ramin
    Baradaran, Behzad
    Zarei, Mohammad
    JOURNAL OF CELLULAR PHYSIOLOGY, 2021, 236 (08) : 5564 - 5581
  • [7] The role of GDF-15 on docetaxel resistance in lung cancer
    Watanabe, Mototsugu
    Masada, Yasutaka
    Hashida, Shinsuke
    Ohtsuka, Tomoaki
    Suzawa, Ken
    Maki, Yuho
    Yamamoto, Hiromasa
    Soh, Junichi
    Asano, Hiroaki
    Tsukuda, Kazunori
    Toyooka, Shinichi
    Miyoshi, Shinichiro
    CANCER RESEARCH, 2015, 75
  • [8] The role of GDF-15, a marker of fibrosis, in cardiogenic shock
    Hongisto, M.
    Harjola, V-P
    Mebazaa, A.
    Kober, L.
    Sionis, A.
    Cardoso, J. Silva
    Pulkki, K.
    Lassus, J.
    EUROPEAN JOURNAL OF HEART FAILURE, 2015, 17 : 349 - 349
  • [9] The role of GDF-15, a marker of fibrosis, in cardiogenic shock
    Hongisto, M.
    Harjola, V. -P.
    Mebazaa, A.
    Kober, L.
    Sionis, A.
    Silva Cardoso, J.
    Pulkki, K.
    Lassus, J.
    EUROPEAN HEART JOURNAL, 2015, 36 : 1180 - 1180
  • [10] GDF-15 as a Weight Watcher for Diabetic and Non-Diabetic People Treated With Metformin
    Ouyang, Jing
    Isnard, Stephane
    Lin, John
    Fombuena, Brandon
    Peng, Xiaorong
    Chen, Yaokai
    Routy, Jean-Pierre
    FRONTIERS IN ENDOCRINOLOGY, 2020, 11